On the heels of successful patient treatments in Panama City, Panama, Francis Medical is overcoming challenges brought on by the COVID-19 pandemic to bring their ground-breaking water vapor technology to men dealing with prostate cancer.
October 16, 2019: Dr. Jonathan Jarow joins Francis Medical, Inc. as the company’s chief medical officer (CMO) to lead Francis Medical’s clinical and regulatory efforts, including the VAPOR trials evaluating water vapor ablation as a minimally invasive treatment for prostate cancer.
December 17, 2018: Francis Medical, Inc. has been featured in BioWorld MedTech, a leading news source of advances in medical technology.
December 13, 2018: Francis Medical announces the completion of a $18.0 million round of Series A funding. Arboretum Ventures led the Series A with co-investments from H2Oey Ventures (an affiliate of Solas BioVentures Fund), Tonkawa, and Boston Scientific. Francis Medical plans to use this capital to further develop the company's cancer ablation therapy.